세계의 혈소판 시장 보고서(2025년)

Blood platelets, also known as thrombocytes, are small, disc-shaped cell fragments found in the blood that play a crucial role in clot formation and wound healing. They prevent excessive bleeding by adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent significant blood loss. Produced in the bone marrow, platelets are vital for hemostasis and blood vessel repair.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of platelets in the blood platelet market are whole blood-derived platelets and apheresis-derived platelets. Whole blood-derived platelets are obtained by separating platelets from a standard whole blood donation, often pooled from multiple donors for transfusion. These platelets are used for treating platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications. The primary end-users of these platelets include hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment centers, trauma centers, and others.

The blood platelets market research report is one of a series of new reports from The Business Research Company that provides blood platelets market statistics, including blood platelets industry global market size, regional shares, competitors with a blood platelets market share, detailed blood platelets market segments, market trends and opportunities, and any further data you may need to thrive in the blood platelets industry. This blood platelets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood platelets market size has grown strongly in recent years. It will grow from$6.27 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing number of surgeries, the rising incidence of traumatic injuries, the 6.27% prevalence of autoimmune diseases, the growing incidence of chronic diseases, and the increasing prevalence of thrombocytopenia.

The blood platelets market size is expected to see strong growth in the next few years. It will grow to$8.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing number of trauma cases, the rise in the number of blood banks, a growing preference for allogeneic blood transfusion therapies, the aging population, and the increasing need for platelets in wound healing. Key trends expected during this period include the development of automated platelet apheresis systems, advancements in platelet storage technologies, platelet-rich plasma (PRP) therapies, a shift toward leukoreduced platelets, the emergence of artificial platelet substitutes, gene editing for platelet disorders, and automated donor screening.

The growing prevalence of blood disorders is expected to propel the expansion of the blood platelets market. Blood disorders refer to conditions that impact the function, production, or components of blood, including red blood cells, white blood cells, platelets, or plasma, leading to issues such as anemia, clotting disorders, or immune system deficiencies. The increasing prevalence of these disorders is largely due to the aging population, as the natural decline in bone marrow function with age makes older adults more vulnerable to conditions such as anemia, thrombocytopenia, and clotting disorders. Blood platelets are crucial in the treatment of blood disorders, as they regulate blood clotting, preventing excessive bleeding and supporting wound healing. For example, in April 2024, the Perth Blood Institute, a non-profit organization based in Australia, reported that the number of people diagnosed with hemophilia, a rare genetic disorder where blood doesn't clot properly due to a lack of clotting factors, reached 257,146 in 2022, up from 233,577 in 2021. Therefore, the rising prevalence of blood disorders is significantly contributing to the growth of the blood platelets market.

Major players in the blood platelet market are focusing on developing innovative solutions such as platelet pooling to extend shelf life, improve availability, and assist blood centers in meeting the increasing demand for transfusions. Platelet pooling involves combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, thereby improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. This innovation extends the shelf life of whole blood-derived platelets from five to seven days, improving platelet availability for transfusion. It also offers an alternative platelet supply to address rising demand and donor shortages, helping blood centers enhance inventory management and reduce waste.

In December 2023, Sysmex Corporation, a Japan-based healthcare and diagnostics company, increased its stake in Megakaryon Corporation for an undisclosed amount. With this acquisition, Sysmex aims to accelerate the commercialization of high-quality, induced pluripotent stem (iPS) cell-derived platelets by utilizing Megakaryon's technology, strengthening synergies within the group, and advancing regenerative medicine through automation and quality control innovations. Megakaryon Corporation, a Japan-based biotechnology company, specializes in the production of iPS cell-derived platelets for safer and more sustainable blood transfusions.

Major players in the blood platelets market are Pfizer Inc., Johnson & Johnson, Bayer AG, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma Inc., LFB Group, Bio Products Laboratory Limited, Sanquin, Macopharma, Biotest AG, Cerus Corporation, ADMA Biologics Inc., Octapharma AG, Kamada Ltd., and HemaCare.

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood platelets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blood platelets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood platelets market consists of sales of platelet apheresis kits, platelet storage systems, platelet-derived growth factors (PDGFs), platelet function analyzers and platelet transfusion services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Platelets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood platelets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood platelets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood platelets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets
• 2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication
• 3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users
• Subsegments:
• 1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets
• 2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Fresenius Kabi; Takeda Pharmaceutical Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Platelets Market Characteristics

3. Blood Platelets Market Trends And Strategies

4. Blood Platelets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Platelets Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Platelets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Platelets Market Growth Rate Analysis
• 5.4. Global Blood Platelets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Platelets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Platelets Total Addressable Market (TAM)

6. Blood Platelets Market Segmentation

• 6.1. Global Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Blood Derived Platelets
• Apheresis Derived Platelets
• 6.2. Global Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Function Disorder
• Hemophilia
• Thrombocytopenia
• Perioperative Indication
• 6.3. Global Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Blood Banks
• Research Laboratories
• Specialty Clinics
• Cancer Treatment Centers
• Trauma Centers
• Other End Users
• 6.4. Global Blood Platelets Market, Sub-Segmentation Of Whole Blood Derived Platelets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukocyte-Reduced Whole Blood Platelets
• Non-Leukocyte-Reduced Whole Blood Platelets
• Pathogen-Reduced Whole Blood Platelets
• 6.5. Global Blood Platelets Market, Sub-Segmentation Of Apheresis Derived Platelets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Donor Apheresis Platelets
• Leukocyte-Reduced Apheresis Platelets
• Pathogen-Reduced Apheresis Platelets

7. Blood Platelets Market Regional And Country Analysis

• 7.1. Global Blood Platelets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Platelets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Platelets Market

• 8.1. Asia-Pacific Blood Platelets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Platelets Market

• 9.1. China Blood Platelets Market Overview
• 9.2. China Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Platelets Market

• 10.1. India Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Platelets Market

• 11.1. Japan Blood Platelets Market Overview
• 11.2. Japan Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Platelets Market

• 12.1. Australia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Platelets Market

• 13.1. Indonesia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Platelets Market

• 14.1. South Korea Blood Platelets Market Overview
• 14.2. South Korea Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Platelets Market

• 15.1. Western Europe Blood Platelets Market Overview
• 15.2. Western Europe Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Platelets Market

• 16.1. UK Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Platelets Market

• 17.1. Germany Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Platelets Market

• 18.1. France Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Platelets Market

• 19.1. Italy Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Platelets Market

• 20.1. Spain Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Platelets Market

• 21.1. Eastern Europe Blood Platelets Market Overview
• 21.2. Eastern Europe Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Platelets Market

• 22.1. Russia Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Platelets Market

• 23.1. North America Blood Platelets Market Overview
• 23.2. North America Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Platelets Market

• 24.1. USA Blood Platelets Market Overview
• 24.2. USA Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Platelets Market

• 25.1. Canada Blood Platelets Market Overview
• 25.2. Canada Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Platelets Market

• 26.1. South America Blood Platelets Market Overview
• 26.2. South America Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Platelets Market

• 27.1. Brazil Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Platelets Market

• 28.1. Middle East Blood Platelets Market Overview
• 28.2. Middle East Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Platelets Market

• 29.1. Africa Blood Platelets Market Overview
• 29.2. Africa Blood Platelets Market, Segmentation By Platelet Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Platelets Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Platelets Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Platelets Market Competitive Landscape And Company Profiles

• 30.1. Blood Platelets Market Competitive Landscape
• 30.2. Blood Platelets Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Platelets Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. CSL Limited
• 31.3. Grifols S.A.
• 31.4. Terumo Corporation
• 31.5. American Red Cross
• 31.6. BioMarin Pharmaceutical Inc.
• 31.7. Miltenyi Biotec
• 31.8. Kedrion Biopharma Inc.
• 31.9. LFB Group
• 31.10. Bio Products Laboratory Limited
• 31.11. Sanquin
• 31.12. Macopharma
• 31.13. Biotest AG
• 31.14. Cerus Corporation
• 31.15. ADMA Biologics Inc.

32. Global Blood Platelets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Platelets Market

34. Recent Developments In The Blood Platelets Market

35. Blood Platelets Market High Potential Countries, Segments and Strategies

• 35.1 Blood Platelets Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Platelets Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Platelets Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34782_Blood_Platelets_GMR_2025